[1]
Neuhaus, T., Luyken, J. and Stier, S. 2014. Discontinuation of the Tyrosine Kinase Inhibitor Sunitinib in Patients with Metastatic Renal Cell Carcinoma: A Case Series. Urology Journal. 11, 2 (May 2014), 1494–1498. DOI:https://doi.org/10.22037/uj.v11i2.1672.